Immune Design Corp. 4
4 · Immune Design Corp. · Filed Jan 6, 2017
Insider Transaction Report
Form 4
COLEMAN LEWIS W
Director
Transactions
- Award
Stock Option (right to buy)
2017-01-04+10,000→ 10,000 totalExercise: $5.60Exp: 2027-01-04→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The shares underlying the option will become fully vested on January 4, 2018, subject to the Reporting Person's continuous service through such date.